Loading...

JAGX JAGUAR HEALTH INC Delisting Actions 8-K Filing

JGR

JGX

JAGUAR HEALTH INC

(JAGX)

2026 8-K

Equity Line Credit

Annual Meeting Results

Stock Exchange Agreements

Listing Compliance Update

Stock Exchange Update

Q1 2026 Results

Preferred Stock Exchange

Compliance Extension Granted

Stock Compliance Update

Delisting Notification

Stock Listing Status

Share Increase Approved

Financial Update

Earnings Announcement

Royalty Agreement Update

Nasdaq Delisting Notice

Preferred Stock Dividend

Dividend Announcement

Royalty Interest Exchange

License Agreement Announced

Filing Amendment

Financial Agreement Update

Funding Agreement

Stock Exchange Agreement

Stockholder Meeting Results

Royalty Amendments Announced

Financing Agreement Signed

Equity Exchange Agreement

Securities Purchase Agreement

PIPE Financing Agreement

Annual Meeting Results

ATM Agreement Update

Equity Offerings

Debt Restructuring

Equity Offerings

Equity Offerings

Investor Meetings

Equity Offerings

Product Expansion

Investor Meetings

Debt Restructuring

Investor Meetings

Investor Presentation

Private Placement

Earnings Announcement

Securities Agreement

Stock Split Announcement

Stockholder Meeting

Dividend Declaration

ATM Agreement Amendment

Q3 Earnings Report

Q2 Earnings Report

FDA Trial Results

Amendment to Offering Agree...

Equity Issuance

Nasdaq Listing Compliance

Annual Meeting Results

Equity Issuance

Amendment to At the Market ...

Special Meeting Results

Securities Purchase and Exc...

Equity Disinvestment

Debt Extinguishment and Exc...

Lease Agreement Amendments

Amendments and Exchange Agr...

Earnings Reports

Management Changes

Amendment to Inducement Awa...

Earnings Reports

Private Placement

Earnings Reports

Nasdaq Listing Compliance

Termination of License Agre...

Reverse Stock Split

External Links:

On May 26, 2026, Jaguar Health, Inc. confirmed it regained compliance with Nasdaq's Bid Price Rule, but must maintain a minimum bid price for 30 consecutive days to avoid delisting; the Nasdaq panel will continue monitoring until September 1, 2026.

AI Assistant

JAGUAR HEALTH INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.